The innovative drug sector has been volatile but on the rise, with Jibei Biotech jumping by 10% and Kangchen Pharm, Fuxiang Pharm, and Kanghong Pharm all up by over 5%. Other pharmaceutical companies such as Betta Pharma, MiMedx, Yutai Pharma, Fosun Pharma, and Sanofi Genzyme have also followed the upward trend. In terms of news, the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting will take place from June 2 to June 6, 2023. The release of abstracts at ASCO marks an important milestone in the validation of products during the developmental stage, and the research breakthroughs of overseas pharmaceutical companies directly affect China's drug development strategy.